Preclinical development of new tetrahydrofuran derivatives targeting the sigma-1 chaperone protein as neuroprotectants in Alzheimer’s disease.
Alzheimer’s Association International Conference, July 16-21, 2011, Paris, France Tangui Maurice, Vanessa Villard, Johann Meunier, Valentine Lahmy, Emeline Keller and Alexandre Vamvakides View Poster